Sexually transmitted diseases (STDs)

Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Tests and diagnosis

By Mayo Clinic staff

If your sexual history and current signs and symptoms suggest that you have an STI, laboratory tests can identify the cause and detect coinfections you might also have contracted.

  • Blood tests. Blood tests can confirm the diagnosis of HIV or later stages of syphilis.
  • Urine samples. Some STIs can be confirmed with a urine sample.
  • Fluid samples. If you have active genital sores, testing fluid and samples from the sores may be done to diagnose the type of infection. Laboratory tests of material from a genital sore or discharge are used to diagnose the most common bacterial and some viral STIs at an early stage.

Screening
Testing for a disease in someone who doesn't have symptoms is called screening. Most of the time, STI screening is not a routine part of health care. But there are exceptions:

  • Everyone. The one STI screening test suggested for everyone ages 13 to 64 is a blood or saliva test for human immunodeficiency virus (HIV), the virus that causes AIDS. Most health care settings in the United States offer a rapid HIV test with same-day results.
  • Pregnant women. Screening for HIV, hepatitis B, chlamydia and syphilis generally takes place at the first prenatal visit for all pregnant women. Gonorrhea and hepatitis C screening tests are recommended at least once during pregnancy for women at high risk of these infections.
  • Women age 21 and older. The Pap test screens for cervical abnormalities, including inflammation, precancerous changes and cancer, which is caused by certain strains of human papillomavirus (HPV). Experts recommend that, starting at age 21, women should have a Pap test at least every three years. Some experts also advise that women who start having sex before age 21 should have a Pap test within three years of first intercourse.
  • Women under age 25 who are sexually active. All sexually active women under age 25 should be tested for chlamydia infection. The chlamydia test uses a sample of urine or vaginal fluid you can collect yourself. Some experts recommend repeating the chlamydia test three months after you've had a positive test and been treated. The second test is needed to confirm that the infection is cured, as reinfection by an untreated or undertreated partner is common. A bout of chlamydia doesn't protect you from future exposures. You can catch the infection again and again, so you should get retested if you have a new partner. Screening for gonorrhea is also recommended in sexually active women under age 25.
  • Men who have sex with men. Compared with other groups, men who have sex with men run a higher risk of acquiring STIs. Many public health groups recommend annual or more frequent STI screening for these men. Regular tests for HIV, syphilis, chlamydia and gonorrhea are particularly important. Evaluation for herpes and hepatitis B also may be recommended.
  • People with HIV. If you have HIV, it dramatically raises your risk of catching other STIs. Experts recommend frequent syphilis, gonorrhea, chlamydia and herpes tests for people with HIV. Women with HIV may develop aggressive cervical cancer, so they should have Pap tests twice a year to screen for HPV. Some experts also recommend regular HPV screening of HIV-infected men who risk anal cancer from HPV contracted anally.
References
  1. Dorland's Illustrated Medical Dictionary. 31st ed. Philadelphia, Pa.: W.B. Saunders; 2008. http://dorlands.com/def.jsp. Accessed Jan., 2011.
  2. Swygard H. Screening for sexually transmitted diseases. http://www.uptodate.com/home/index.html. Accessed Jan. 25, 2011.
  3. Holmes KK. Sexually transmitted infections: Overview and clinical approach. In: Fauci AS, et al. Harrison's Online. 17th ed. New York, N.Y.: The McGraw-Hill Companies; 2008. http://www.accessmedicine.com/content.aspx?aid=2893718. Accessed Jan. 25, 2011.
  4. Global strategy for the prevention and control of sexually transmitted infections: 2006-2015. Breaking the chain of transmission. World Health Organization. http://www.who.int/reproductive-health/publications/stisstrategy/index.html. Accessed Jan. 25, 2011.
  5. Basic information: HIV. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/topics/basic/index.htm. Accessed Jan. 25, 2011.
  6. CDC fact sheet: Genital herpes. Centers for Disease Control and Prevention. http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Accessed Jan. 25, 2011.
  7. CDC fact sheet: Genital HPV infection. Centers for Disease Control and Prevention. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed Jan. 25, 2011.
  8. CDC fact sheet: Syphilis. Centers for Disease Control and Prevention. http://www.cdc.gov/std/Syphilis/STDFact-Syphilis.htm. Accessed Jan. 25, 2011.
  9. CDC fact sheet: Chlamydia. Centers for Disease Control and Prevention. http://www.cdc.gov/std/chlamydia/STDFact-Chlamydia.htm. Accessed Jan. 25, 2011.
  10. CDC fact sheet: Gonorrhea. Centers for Disease Control and Prevention. http://www.cdc.gov/std/gonorrhea/STDFact-gonorrhea.htm. Accessed Jan. 25, 2011.
  11. Centers for Disease Control and Prevention, et al. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommendations and Reports. 2010;59:1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5511a1.htm. Accessed Jan. 25, 2011.
  12. CDC fact sheet: Bacterial vaginosis. Centers for Disease Control and Prevention. http://www.cdc.gov/std/bv/STDFact-Bacterial-Vaginosis.htm. Accessed Jan. 25, 2011.
  13. CDC fact sheet: PID (pelvic inflammatory disease). Centers for Disease Control and Prevention. http://www.cdc.gov/std/PID/STDFact-PID.htm. Accessed Jan. 25, 2011.
  14. CDC fact sheet: Trichomoniasis. Centers for Disease Control and Prevention. http://www.cdc.gov/std/trichomonas/STDFact-Trichomoniasis.htm. Accessed Jan. 25, 2011.
  15. Centers for Disease Control and Prevention, et al. Shigella flexneri serotype 3 infections among men who have sex with men — Chicago, Illinois, 2003-2004. MMWR. 2005;54:820. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5433a2.htm. Accessed Jan. 25, 2011.
  16. Quick answers: Sexually transmitted diseases. McGraw Hill's Access Medicine. http://www.accessmedicine.com/popup.aspx?aID=3271836. Accessed Jan. 25, 2011.
  17. Klausner JD. Screening guidelines for sexually transmitted diseases, including HIV. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3025000. Accessed Jan. 25, 2011.
  18. Swygard H, et al. Gonorrhea. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3025486. Accessed Jan. 25, 2011.
  19. Ward H. Prevention strategies for sexually transmitted infections: Importance of sexual network and epidemic phase. Sexually Transmitted Infections. 2007;83:i43.
  20. Trends in sexually transmitted diseases in the United States: 2009 national data for gonorrhea, chlamydia and syphilis. Centers for Disease Control and Prevention. http://www.cdc.gov/STI/stats07/trends.htm. Accessed Jan. 25, 2011.
  21. Arrington-Sanders R, et al. Sexually transmitted diseases in adolescents. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3026189. Accessed Jan. 25, 2011.
  22. Wong W. Sexually transmitted diseases in men who have sex with men. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3026252. Accessed Jan. 25, 2011.
  23. Peterman TA. Partner notification and management. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3026469. Accessed Jan. 25, 2011.
  24. Klausner JD. The sexual history. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/popup.aspx?aid=3026901. Accessed Jan. 25, 2011.
  25. Safer sex ("Safe sex"). Planned Parenthood. http://www.plannedparenthood.org/health-topics/STIs-hiv-safer-sex/safer-sex-4263.htm. Accessed Jan. 25, 2011.
  26. Reitmeijer CA. Principles of risk reduction counseling. In: Klausner JD, et al. Current Diagnosis and Treatment of Sexually Transmitted Diseases. New York, N.Y.: The McGraw Hill Companies; 2007. http://www.accessmedicine.com/content.aspx?aid=3026418. Accessed Jan. 25, 2011.
  27. Centers for Disease Control and Prevention, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR Recommendations and Reports. 2005;54:1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm. Accessed Jan. 25, 2011.
  28. Centers for Disease Control and Prevention, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recommendations and Reports. 2006;55:1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm?s_cid=rr5514a1_e. Accessed Jan. 25, 2011.
  29. Centers for Disease Control and Prevention, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports. 2011:60;1705.
DS01123 Jan. 20, 2012

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger